Title:
FULLY HUMAN NEUTRALIZING ANTIBODY COMBATING TETANUS TOXIN
Document Type and Number:
WIPO Patent Application WO/2019/128120
Kind Code:
A1
Abstract:
Provided is a fully human neutralizing antibody combating tetanus toxin. Specifically provided is a monoclonal antibody combating tetanus toxoid, having heavy chain CDR1-3 regions as shown in SEQ ID NOs. 1-3 and light chain CDR1-3 regions as shown in SEQ ID NOs. 5-7. Also disclosed are the use of an antibody combating tetanus toxin in prevention and treatment of tetanus infection-related diseases, and the use in detection of tetanus infection. The antibody combating tetanus toxin is a fully human monoclonal antibody, without immunogenicity and with a good specificity, a high affinity and a high valence.
More Like This:
WO/1998/014209 | ORAL ADMINISTRATION OF CHICKEN YOLK ANTIBODIES TO TREAT DISEASE |
WO/1999/010012 | NOVEL priA |
JPH09304380 | ACQUISITION METHOD FOR ANTIGEN AND ITS APPLICATION METHOD |
Inventors:
LIAO HUAXIN (CN)
YUAN XIAOHUI (CN)
WANG YUEMING (CN)
YUAN XIAOHUI (CN)
WANG YUEMING (CN)
Application Number:
PCT/CN2018/090490
Publication Date:
July 04, 2019
Filing Date:
June 08, 2018
Export Citation:
Assignee:
ZHUHAI TRINOMAB BIOTECHNOLOGY CO LTD (CN)
GUANGZHOU TRINOMAB BIOTECHNOLOGY CO LTD (CN)
GUANGZHOU TRINOMAB BIOTECHNOLOGY CO LTD (CN)
International Classes:
C07K16/12; A61K39/40; A61P21/02; C12N15/13
Foreign References:
CN1634991A | 2005-07-06 | |||
CN105153305A | 2015-12-16 | |||
CN102206275A | 2011-10-05 | |||
CN102875674A | 2013-01-16 | |||
EP0562132A1 | 1993-09-29 | |||
JPH0257195A | 1990-02-26 | |||
KR100624011B1 | 2006-09-19 |
Other References:
MEIJER, P.J.: "Isolation of Human Antibody Repertoires with Preservation of the Natural Heavy and Light Chain Pairing", J.MOL. BIOL., 2 March 2006 (2006-03-02)
MEIJER, P. J.: "AY867181.1: Homo sapiens clone 135d06 anti-tetanus toxoid immunoglobulin light chain variable region (IGL@) mRNA, partial cds", NCBI GENBANK, 26 July 2016 (2016-07-26)
MEIJER, P. J.: "AY867181.1: Homo sapiens clone 135d06 anti-tetanus toxoid immunoglobulin light chain variable region (IGL@) mRNA, partial cds", NCBI GENBANK, 26 July 2016 (2016-07-26)
Attorney, Agent or Firm:
BEIJING MIZAR STAR INTELLECTUAL PROPERTY AGENCY (CN)
Download PDF: